OverviewSuggest Edit

OraSure Technologies develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The Company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. In addition, the Company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing, immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications, an oral fluid HIV-1 confirmatory test and rapid point-of-care saliva alcohol test.

TypePublic
Founded1987
HQBethlehem, US
Websiteorasure.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Dec 2019)472(+19%)
Job Openings56
Revenue (FY, 2019)$154.6 M(-14%)
Share Price (Sept 2020)$11 (-1%)
Cybersecurity ratingBMore

Key People/Management at OraSure Technologies

Michael Celano

Michael Celano

Chairman of the Board
Jack E. Jerrett

Jack E. Jerrett

Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Charles W. Patrick

Charles W. Patrick

Director
Mara G. Aspinall

Mara G. Aspinall

Director
Eamonn Hobbs

Eamonn Hobbs

Director
Kathleen Weber

Kathleen Weber

Executive Vice President, Business Unit Leader, Molecular Solutions
Show more

OraSure Technologies Office Locations

OraSure Technologies has an office in Bethlehem
Bethlehem, US (HQ)
220 E 1st St
Bethlehem, US
150 Webster St
Bethlehem, US
1745 Eaton Ave
Show all (3)

OraSure Technologies Financials and Metrics

OraSure Technologies Revenue

Embed Graph
View revenue for all periods
OraSure Technologies's revenue was reported to be $154.61 m in FY, 2019
USD

Revenue (Q2, 2020)

29.3m

Gross profit (Q2, 2020)

17.3m

Gross profit margin (Q2, 2020), %

59%

Net income (Q2, 2020)

(10.5m)

EBIT (Q2, 2020)

(9.4m)

Market capitalization (15-Sept-2020)

786.4m

Closing stock price (15-Sept-2020)

11.0

Cash (30-Jun-2020)

173.9m

EV

618.9m
OraSure Technologies's current market capitalization is $786.4 m.
USDQ2, 2011

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.2 x
Show all financial metrics

OraSure Technologies Operating Metrics

FY, 2016

Facilities

2

Patents (US)

29
Show all operating metrics

OraSure Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

OraSure Technologies Revenue Breakdown

Embed Graph

OraSure Technologies revenue breakdown by business segment: 74.9% from OSUR and 25.1% from DNAG

OraSure Technologies Online and Social Media Presence

Embed Graph

OraSure Technologies News and Updates

Thinking about buying stock in OraSure Technologies, FuelCell Energy, Norwegian Cruise Line, Zynga Inc, or Nio Inc?

NEW YORK, Sept. 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSUR, FCEL, NCLH, ZNGA, and NIO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock

BETHLEHEM, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced the pricing of an underwritten offering of 8,000,000 shares of its common stock at a price of $11.00 per share. After the underwriting discount and estimated off…

OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.

Acquisition strengthens OraSure’s leadership position in HIV field Acquisition strengthens OraSure’s leadership position in HIV field

Thinking about trading stocks or options in Burlington Stores, Floor & Decor Holdings, Sea Ltd, OraSure Technologies, or American Airlines Group?

NEW YORK, May 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BURL, FND, SE, OSUR, and AAL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test

BETHLEHEM, Pa., April 06, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced it has been awarded a $710,310 contract from the Biomedical Advan…

OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

BETHLEHEM, Pa., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 38TH Annual J.P. Morga…
Show more

OraSure Technologies Blogs

Greater Than AIDS, With Support From Walgreens and OraSure Technologies, to Provide 10,000 Free In-Home HIV Tests to Community Partners

Greater Than AIDS, With Support From Walgreens and OraSure Technologies, to Provide 10,000 Free In-Home HIV Tests to Community Partners alfredo.macaba… Thu, 06/25/2020 - 19:06 Greater Than AIDS, With Support From Walgreens and OraSure Technologies, to Provide 10,000 Free In-Home HIV Tests …

Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study

PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC).

OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples

OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples Content Import Wed, 06/10/2020 - 08:01 OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples Jun 10,2020 This rele…

Lisa Nibauer

Lisa Nibauer alfredo.macaba… Tue, 06/09/2020 - 12:26 Lisa Nibauer Executive Vice President, Business Unit Leader, Infectious Disease Lisa Nibauer joined OraSure as Executive Vice President, Business Unit Leader, Infectious Disease in May…

OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test

OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test Content Import Mon, 06/08/2020 - 08:02 OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test Jun 08,202…

Lelio Marmora

Lelio Marmora alfredo.macaba… Thu, 06/04/2020 - 09:42 Member of the Audit Committee Member of the Nominating and Corporate Governance Committee Lelio Marmora Former Executive Director, Unitaid Lelio Marmora became a member of the board…
Show more

OraSure Technologies Frequently Asked Questions

  • When was OraSure Technologies founded?

    OraSure Technologies was founded in 1987.

  • Who are OraSure Technologies key executives?

    OraSure Technologies's key executives are Michael Celano, Jack E. Jerrett and Charles W. Patrick.

  • How many employees does OraSure Technologies have?

    OraSure Technologies has 472 employees.

  • What is OraSure Technologies revenue?

    Latest OraSure Technologies annual revenue is $154.6 m.

  • What is OraSure Technologies revenue per employee?

    Latest OraSure Technologies revenue per employee is $327.6 k.

  • Who are OraSure Technologies competitors?

    Competitors of OraSure Technologies include InBios International, ROXALL and Nmc Health.

  • Where is OraSure Technologies headquarters?

    OraSure Technologies headquarters is located at 220 E 1st St, Bethlehem.

  • Where are OraSure Technologies offices?

    OraSure Technologies has an office in Bethlehem.

  • How many offices does OraSure Technologies have?

    OraSure Technologies has 3 offices.